| Sector |
Chemicals
|
Compare with Sector peers |
| Industry |
Chemicals
|
Compare with Industry peers |
| Website | http://www.gblinfra.com | |
| Financial Indicators | ||
|---|---|---|
| Market Cap | 515.09 Cr. | |
| Earnings per share (EPS) | 3.51 | Trailing Twelve Months Ending 2021-03 |
| Price-Earning Ratio (PE) | 23.54 | Trailing Twelve Months Ending 2021-03 |
| Industry PE | 48.55 | Trailing Twelve Months Ending 2021-03 |
| Book Value / Share | 37.27 | Trailing Twelve Months Ending 2021-03 |
| Price to Book Value | 2.22 | Calculated using Price: 82.60 |
| Dividend Yield | 0.00 | Period Ending 2020-03 |
| No. of Shares Subscribed | 6.24 Cr. | 62,359,421 Shares |
| FaceValue | 1 | |
| Company Profile | ||
|
Ganesh Benzoplast was established in 1974. It has 34 years of experience which assists it in offering top quality specialty chemicals, drug intermediates, pharmaceutical intermediates, bulk drug intermediates such as sodium benzoate, benzoic acid, ferrous fumarate, phenobarbitone, petroleum sulphonates, lubricant additives and components. The range is quality-tested on various parameters in compliance with international standards as well as in accordance with emerging needs of our clients. Business area of the company: The company is engaged in the manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants, API/bulk drug, etc. Product offered by the company:
|
||
Company Profile
Ganesh Benzoplast was established in 1974. It has 34 years of experience which assists it in offering top quality specialty chemicals, drug intermediates, pharmaceutical intermediates, bulk drug intermediates such as sodium benzoate, benzoic acid, ferrous fumarate, phenobarbitone, petroleum sulphonates, lubricant additives and components. The range is quality-tested on various parameters in compliance with international standards as well as in accordance with emerging needs of our clients.
Business area of the company:
The company is engaged in the manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants, API/bulk drug, etc.
Product offered by the company:
| 1 Day |
|
-1.14% |
| 1 Week |
|
-4.07% |
| 1 Month |
|
+1.98% |
| 3 Month |
|
+34.97% |
| 6 Month |
|
+44.79% |
| 1 Year |
|
+122.34% |
| 2 Year |
|
+154.94% |
| 5 Year |
|
+180.0% |
| 3 years | 2018-03 | 2019-03 | 2020-03 | |
| Return on Equity (%) | 100.66 | 32.64 | 26.25 | |
| Return on Capital Employed (%) | 55.10 | 24.06 | 22.37 | |
| Return on Assets (%) | 33.81 | 12.77 | 12.99 |
| Particulars | 3 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Shh. Funds | 81 | 112 | 146 | |
| Non Curr. Liab. | 68 | 46 | 46 | |
| Curr. Liab. | 90 | 93 | 76 | |
| Minority Int. | ||||
| Equity & Liab. | 239 | 251 | 267 | |
| Non Curr. Assets | 170 | 183 | 184 | |
| Curr. Assets | 68 | 68 | 83 | |
| Misc. Exp. not W/O | ||||
| Total Assets | 239 | 251 | 267 |
| Particulars | 3 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Net Sales | 169 | 212 | 247 | |
| Other Income | 1 | 1 | 0 | |
| Total Income | 170 | 213 | 247 | |
| Total Expenditure | -117 | -156 | -184 | |
| PBIDT | 53 | 57 | 64 | |
| Interest | -11 | -10 | -9 | |
| Depreciation | -12 | -12 | -13 | |
| Taxation | ||||
| Exceptional Items | 51 | -3 | -7 | |
| PAT | 81 | 31 | 34 |
| Particulars | 3 years | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. |
| Cash Fr. Operatn. | 39 | 60 | 27 | |
| Cash Fr. Inv. | -19 | -27 | -13 | |
| Cash Fr. Finan. | -21 | -30 | -14 | |
| Net Change | -1 | 3 | 0 | |
| Cash & Cash Eqvt | 0 | 3 | 3 |
|
Tue, 13 Jul 2021
Shareholding for the Period Ended June 30 2021 Ganesh Benzoplast Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here |
||||||||||||||
|
Mon, 12 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
|
||||||||||||||
|
Mon, 12 Jul 2021
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulation 2018 we enclose herewith the confirmation certificate dated July 05 2021 received from M/s Bigshare Services Pvt. Ltd. Registrar and Share Transfer Agent of the Company for the quarter ended on June 30 2021. |
| Fri, 23 Jul 2021 |
Strongly Outperforming Benchmark Index
|
Close Within 2 Year High Zone
|
Both SRS And ARS Above Zero
|
| Thu, 22 Jul 2021 |
|
Strongly Outperforming Benchmark Index
|
|
Close Within 2 Year High Zone
|
Equities
M.F.
Sectors